Long?term Survival Associated with Crizotinib in a Lung Cancer Patient with a Pulmonary Artery Embolism
To the Editor:Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a common complication in cancer patients, and the overall risk of VTE in patients with a malignancy was 7?fold as high as that for patients without cancer.[1] Herein, we report a case of long?term survival associated with crizotinib in an anaplastic lymphoma kinase (ALK)?positive lung cancer patient with a pulmonary artery embolism.
更多- 翻译满意度评价:
- 提交
- 浏览:26
- 被引:2
- 下载:28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文